A Study of the ILB-3101 in Patients with Advanced Solid Tumors

Clinical trial NCT06426680 · RECRUITING

Trial details

NCT number: NCT06426680
Sponsor: Innolake Biopharm
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2024-10-30
Primary completion: 2025-12-01
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.